Global Insulin Glargine Market Analysis and Forecast 2024-2030

Global Insulin Glargine Market Analysis and Forecast 2024-2030


Summary

nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a peakless profile (according to the insulin glargine package insert).

According to APO Research, The global Insulin Glargine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Insulin Glargine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Insulin Glargine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Insulin Glargine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Insulin Glargine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Insulin Glargine include Sanofi-Aventis, Ganlee and Biocon, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Insulin Glargine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Insulin Glargine, also provides the sales of main regions and countries. Of the upcoming market potential for Insulin Glargine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Insulin Glargine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Insulin Glargine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Insulin Glargine sales, projected growth trends, production technology, application and end-user industry.

Insulin Glargine segment by Company

Sanofi-Aventis
Ganlee
Biocon
Insulin Glargine segment by Type

Single Dose Vial
Pre-filled Syringe
Insulin Glargine segment by Application

Treat Type2 Diabetes
Treat Type1 Diabetes
Insulin Glargine segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Glargine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Insulin Glargine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Glargine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Insulin Glargine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Insulin Glargine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Insulin Glargine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Insulin Glargine Market by Type
1.2.1 Global Insulin Glargine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 Insulin Glargine Market by Application
1.3.1 Global Insulin Glargine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Treat Type2 Diabetes
1.3.3 Treat Type1 Diabetes
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Insulin Glargine Market Dynamics
2.1 Insulin Glargine Industry Trends
2.2 Insulin Glargine Industry Drivers
2.3 Insulin Glargine Industry Opportunities and Challenges
2.4 Insulin Glargine Industry Restraints
3 Global Market Growth Prospects
3.1 Global Insulin Glargine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Insulin Glargine Revenue by Region
3.2.1 Global Insulin Glargine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Insulin Glargine Revenue by Region (2019-2024)
3.2.3 Global Insulin Glargine Revenue by Region (2025-2030)
3.2.4 Global Insulin Glargine Revenue Market Share by Region (2019-2030)
3.3 Global Insulin Glargine Sales Estimates and Forecasts 2019-2030
3.4 Global Insulin Glargine Sales by Region
3.4.1 Global Insulin Glargine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Insulin Glargine Sales by Region (2019-2024)
3.4.3 Global Insulin Glargine Sales by Region (2025-2030)
3.4.4 Global Insulin Glargine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Insulin Glargine Revenue by Manufacturers
4.1.1 Global Insulin Glargine Revenue by Manufacturers (2019-2024)
4.1.2 Global Insulin Glargine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Insulin Glargine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Insulin Glargine Sales by Manufacturers
4.2.1 Global Insulin Glargine Sales by Manufacturers (2019-2024)
4.2.2 Global Insulin Glargine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Insulin Glargine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Insulin Glargine Sales Price by Manufacturers (2019-2024)
4.4 Global Insulin Glargine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Insulin Glargine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Insulin Glargine Manufacturers, Product Type & Application
4.7 Global Insulin Glargine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Insulin Glargine Market CR5 and HHI
4.8.2 2023 Insulin Glargine Tier 1, Tier 2, and Tier 3
5 Insulin Glargine Market by Type
5.1 Global Insulin Glargine Revenue by Type
5.1.1 Global Insulin Glargine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Insulin Glargine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Insulin Glargine Revenue Market Share by Type (2019-2030)
5.2 Global Insulin Glargine Sales by Type
5.2.1 Global Insulin Glargine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Insulin Glargine Sales by Type (2019-2030) & (M mL)
5.2.3 Global Insulin Glargine Sales Market Share by Type (2019-2030)
5.3 Global Insulin Glargine Price by Type
6 Insulin Glargine Market by Application
6.1 Global Insulin Glargine Revenue by Application
6.1.1 Global Insulin Glargine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Insulin Glargine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Insulin Glargine Revenue Market Share by Application (2019-2030)
6.2 Global Insulin Glargine Sales by Application
6.2.1 Global Insulin Glargine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Insulin Glargine Sales by Application (2019-2030) & (M mL)
6.2.3 Global Insulin Glargine Sales Market Share by Application (2019-2030)
6.3 Global Insulin Glargine Price by Application
7 Company Profiles
7.1 Sanofi-Aventis
7.1.1 Sanofi-Aventis Comapny Information
7.1.2 Sanofi-Aventis Business Overview
7.1.3 Sanofi-Aventis Insulin Glargine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Sanofi-Aventis Insulin Glargine Product Portfolio
7.1.5 Sanofi-Aventis Recent Developments
7.2 Ganlee
7.2.1 Ganlee Comapny Information
7.2.2 Ganlee Business Overview
7.2.3 Ganlee Insulin Glargine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Ganlee Insulin Glargine Product Portfolio
7.2.5 Ganlee Recent Developments
7.3 Biocon
7.3.1 Biocon Comapny Information
7.3.2 Biocon Business Overview
7.3.3 Biocon Insulin Glargine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Biocon Insulin Glargine Product Portfolio
7.3.5 Biocon Recent Developments
8 North America
8.1 North America Insulin Glargine Market Size by Type
8.1.1 North America Insulin Glargine Revenue by Type (2019-2030)
8.1.2 North America Insulin Glargine Sales by Type (2019-2030)
8.1.3 North America Insulin Glargine Price by Type (2019-2030)
8.2 North America Insulin Glargine Market Size by Application
8.2.1 North America Insulin Glargine Revenue by Application (2019-2030)
8.2.2 North America Insulin Glargine Sales by Application (2019-2030)
8.2.3 North America Insulin Glargine Price by Application (2019-2030)
8.3 North America Insulin Glargine Market Size by Country
8.3.1 North America Insulin Glargine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Insulin Glargine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Insulin Glargine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Insulin Glargine Market Size by Type
9.1.1 Europe Insulin Glargine Revenue by Type (2019-2030)
9.1.2 Europe Insulin Glargine Sales by Type (2019-2030)
9.1.3 Europe Insulin Glargine Price by Type (2019-2030)
9.2 Europe Insulin Glargine Market Size by Application
9.2.1 Europe Insulin Glargine Revenue by Application (2019-2030)
9.2.2 Europe Insulin Glargine Sales by Application (2019-2030)
9.2.3 Europe Insulin Glargine Price by Application (2019-2030)
9.3 Europe Insulin Glargine Market Size by Country
9.3.1 Europe Insulin Glargine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Insulin Glargine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Insulin Glargine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Insulin Glargine Market Size by Type
10.1.1 China Insulin Glargine Revenue by Type (2019-2030)
10.1.2 China Insulin Glargine Sales by Type (2019-2030)
10.1.3 China Insulin Glargine Price by Type (2019-2030)
10.2 China Insulin Glargine Market Size by Application
10.2.1 China Insulin Glargine Revenue by Application (2019-2030)
10.2.2 China Insulin Glargine Sales by Application (2019-2030)
10.2.3 China Insulin Glargine Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Insulin Glargine Market Size by Type
11.1.1 Asia Insulin Glargine Revenue by Type (2019-2030)
11.1.2 Asia Insulin Glargine Sales by Type (2019-2030)
11.1.3 Asia Insulin Glargine Price by Type (2019-2030)
11.2 Asia Insulin Glargine Market Size by Application
11.2.1 Asia Insulin Glargine Revenue by Application (2019-2030)
11.2.2 Asia Insulin Glargine Sales by Application (2019-2030)
11.2.3 Asia Insulin Glargine Price by Application (2019-2030)
11.3 Asia Insulin Glargine Market Size by Country
11.3.1 Asia Insulin Glargine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Insulin Glargine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Insulin Glargine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Insulin Glargine Market Size by Type
12.1.1 MEALA Insulin Glargine Revenue by Type (2019-2030)
12.1.2 MEALA Insulin Glargine Sales by Type (2019-2030)
12.1.3 MEALA Insulin Glargine Price by Type (2019-2030)
12.2 MEALA Insulin Glargine Market Size by Application
12.2.1 MEALA Insulin Glargine Revenue by Application (2019-2030)
12.2.2 MEALA Insulin Glargine Sales by Application (2019-2030)
12.2.3 MEALA Insulin Glargine Price by Application (2019-2030)
12.3 MEALA Insulin Glargine Market Size by Country
12.3.1 MEALA Insulin Glargine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Insulin Glargine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Insulin Glargine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Insulin Glargine Value Chain Analysis
13.1.1 Insulin Glargine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Insulin Glargine Production Mode & Process
13.2 Insulin Glargine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Insulin Glargine Distributors
13.2.3 Insulin Glargine Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings